Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Questions about adjuvant trastuzumab still remain.

× No keyword cloud information.

7 in total

1. The importance of the comparator in economic evaluations: working on the efficiency frontier.

Authors: Mattias Neyt; Hans Van Brabandt
Journal: Pharmacoeconomics Date: 2011-11 Impact factor: 4.981

2. Evaluation of benefit-risk.

Authors: Silvio Garattini
Journal: Pharmacoeconomics Date: 2010 Impact factor: 4.981

3. Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research.

Authors: Kalipso Chalkidou; Andrew Hoy; Peter Littlejohns
Journal: J R Soc Med Date: 2007-10 Impact factor: 5.344

4. Demands for 'off-licence' access to trastuzumab (Herceptin): content analysis of UK newspaper articles.

Authors: Daniel Hind; Allan J Wailoo; Paul Sutcliffe
Journal: Health Expect Date: 2011-03 Impact factor: 3.377

5. Evaluating the efficacy of current clinical practice of adjuvant chemotherapy in postmenopausal women with early-stage, estrogen or progesterone receptor-positive, one-to-three positive axillary lymph node, breast cancer.

Authors: M B Hannouf; M Brackstone; B Xie; G S Zaric
Journal: Curr Oncol Date: 2012-10 Impact factor: 3.677

6. Media influence on Herceptin subsidization in Australia: application of the rule of rescue?

Authors: Ross Mackenzie; Simon Chapman; Glenn Salkeld; Simon Holding
Journal: J R Soc Med Date: 2008-06 Impact factor: 5.344

7. Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group.

Authors: J R Mackey; M Clemons; M A Côté; D Delgado; S Dent; A Paterson; L Provencher; M B Sawyer; S Verma
Journal: Curr Oncol Date: 2008-01 Impact factor: 3.677

7 in total